Mitochondrial Priming Determines Chemotherapeutic Response in Acute Myeloid Leukemia
Gain- and loss-of-function studies of the BCL-2 family of proteins have shown that they can impact chemotherapeutic sensitivity. However, cells contain myriad anti-apoptotic and pro-apoptotic BCL-2 family members making it difficult to predict cell fate decisions based on the initial conditions of...
Main Author: | Vo, Thanh-Trang |
---|---|
Other Authors: | Letai, Anthony George |
Language: | en_US |
Published: |
Harvard University
2013
|
Subjects: | |
Online Access: | http://dissertations.umi.com/gsas.harvard:10384 http://nrs.harvard.edu/urn-3:HUL.InstRepos:10288428 |
Similar Items
-
Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia
by: Knight T, et al.
Published: (2019-04-01) -
Bcl-2 Family Overexpression and Chemoresistance in Acute Myeloid Leukemia
by: de Melo Silva Alex José
Published: (2018-12-01) -
Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
by: Germana Castelli, et al.
Published: (2019-02-01) -
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
by: Svetlana B. Panina, et al.
Published: (2021-04-01) -
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
by: Jonathan R. Sillar, et al.
Published: (2019-10-01)